Alessandra T Ayers
Overview
Explore the profile of Alessandra T Ayers including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
2
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tian T, Ho C, Ayers A, Aaron R, Klonoff D, Ahn D, et al.
Diabetes Care
. 2025 Mar;
PMID: 40072890
Objective: Diabetes devices, including continuous glucose monitors (CGMs) and insulin pumps, may significantly affect environmental sustainability and long-term resilience. Research Design And Methods: This observational study enrolled 49 adults with...
2.
Ho C, Ayers A, Ahn D, Klonoff D
J Diabetes Sci Technol
. 2025 Jan;
19322968241309357.
PMID: 39819165
An Office of the Inspector General (OIG) report on September 19, 2024, highlighted the need for additional oversight of remote patient monitoring (RPM), which is covered by Medicare. OIG noted...
3.
Ayers A, Ho C, Friedman E, Espinoza J, Shah S, Klonoff D
J Diabetes Sci Technol
. 2024 Dec;
:19322968241306129.
PMID: 39707843
The Diabetes Research Hub (DRH) is a centralized data management system and repository that will revolutionize how diabetes data are gathered, stored, analyzed, and utilized for research. By harnessing advanced...
4.
Ayers A, Ho C, Hussain S, Klonoff D
Diabetes Res Clin Pract
. 2024 Nov;
219():111940.
PMID: 39615793
No abstract available.
5.
Rhee C, Gianchandani R, Kerr D, Philis-Tsimikas A, Kovesdy C, Stanton R, et al.
J Diabetes Sci Technol
. 2024 Nov;
19(1):217-245.
PMID: 39611379
This report represents the conclusions of 15 experts in nephrology and endocrinology, based on their knowledge of key studies and evidence in the field, on the role of continuous glucose...
6.
Ho C, Tian T, Ayers A, Aaron R, Phillips V, Wolf R, et al.
BMC Med Inform Decis Mak
. 2024 Nov;
24(1):357.
PMID: 39593074
Background: The large language models (LLMs), most notably ChatGPT, released since November 30, 2022, have prompted shifting attention to their use in medicine, particularly for supporting clinical decision-making. However, there...
7.
Ayers A, Ho C, Kerr D, Cichosz S, Mathioudakis N, Wang M, et al.
J Diabetes Sci Technol
. 2024 Nov;
19(1):246-264.
PMID: 39578435
Artificial intelligence (AI) is increasingly being used to diagnose complications of diabetes. Artificial intelligence is technology that enables computers and machines to simulate human intelligence and solve complicated problems. In...
8.
Shah V, Peters A, Umpierrez G, Sherr J, Akturk H, Aleppo G, et al.
J Diabetes Sci Technol
. 2024 Nov;
19(1):191-216.
PMID: 39517127
With increasing prevalence of obesity and cardiovascular diseases, there is a growing interest in the use of glucagon-like peptide-1 receptor agonists (GLP-1RAs) as an adjunct therapy in type 1 diabetes...
9.
Ho C, Ayers A, Beisswenger P, Chalew S, Schmidt A, Pandey A, et al.
J Diabetes Sci Technol
. 2024 Nov;
19(2):576-581.
PMID: 39508279
The advanced glycation end products (AGEs) Webinar was co-hosted by Diabetes Technology Society and Kitalys Institute on August 8, 2024, with the goal of reviewing progress made in the measurement...
10.
Ho C, Ayers A, Aaron R, Tian T, Sum C, Klonoff D
J Diabetes Sci Technol
. 2024 Nov;
19(2):470-474.
PMID: 39508278
As medical devices become more integrated with wireless technologies, the risks of cyberattacks and data breaches increase, making stringent cybersecurity measures essential. The implementation of rigorous cybersecurity standards is essential...